A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non-small cell lung cancer (NSCLC) Intergroup JBR. 10 [abstract 7018] - Winton,T.; Livingston,R.; Johnson,D. (Proc Am Soc Clin Oncol, 2004)